Visiongain publishes Adhesion Barrier Market Report 2020-2030

29 April 2020
Pharma

Visiongain has launched a new pharma report Adhesion Barrier Market Report 2020-2030: Forecasts by Product (Synthetic Adhesion Barriers, Natural Adhesion Barriers), Formulation (Film/Mesh, Gel, Liquid), Application (Gynecological Surgeries, Abdominal General Surgeries, Orthopedic Surgeries, Orthopedic Surgeries, Neurological Surgeries, Urological Surgeries, Others), and Geography (North America, Latin America, Europe, Asia Pacific, MEA).

The global adhesion barrier market is anticipated to grow at a lucrative CAGR of xyz% and anticipated to reach USD xyz million by 2020. Visiongain anticipates that the global adhesion barrier market is projected to grow on account of the growing incidence of CVDs (Cardio Vascular Diseases) coupled with rising post-surgical adhesions. Further, the growing number of cardiovascular and interventions across the globe fuelling the market growth.

To manage intraoperative bleeding and reduce adhesions, adhesion prevention products are used by surgeons across the globe. The adhesion can occur in any surgery and can lead to post-surgical complications, and thus requires re-surgery to remove the adhesions. It is estimated that in the United States, xyz% of abdominal surgery patients return for adhesion-related complications, and this costs over US $xyz billion annually across the region.

To access the data contained in this document please email contactus@visiongain.com

North America currently dominates the global adhesion barriers market owing to the presence of developed healthcare infrastructure coupled with the presence of major companies such as Baxter, & Johnson and Johnson, across the region. Additionally, the regional market growth is attributed to the growing prevalence of orthopaedic conditions with a high adoption rate of advanced treatment procedures.

However, the Asia Pacific region is anticipated to experience the highest growth in terms of CAGR over the forecast period owing to growing awareness about benefits of adhesion barriers, rising disposable income, and growing healthcare infrastructure across emerging economies of China and India. Additionally, unmet needs of patients and untapped nations in this region have been attracting investments by global players and this is expected to boost the Adhesion Barrier Market growth over the forecast period.

Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations, and launching new products to strengthen their position in the global market. Companies are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the Adhesion Barrier Market.

For instance, on 2nd December 2019; Baxter International Inc. entered into a definitive agreement to acquire Seprafilm Adhesion Barrier and related assets from Sanofi. Seprafilm has a global presence across the United States, China, France, Japan, and South Korea among other economies. The acquisition is anticipated to widen the product portfolio of Baxter and its reach across numerous countries.

The comprehensive market report features companies such as Anika Therapeutics, Atrium Medical Corporation, Baxter International Inc., Becton Dickinson and Company, FzioMed, Integra LifeSciences Holdings Corporation, Johnson & Johnson, Medtronic Plc, Sanofi, Mast Biosurgery, Getinge Group, C. R. Bard, Innocoll Holdings, Betatech Medical among other prominent players. Also the research study offers market estimation and forecast for the period ranging 2020-2030 for global markets such as North America, Latin America, Europe, Asia Pacific and MEA along with regional sub-markets as U.S., Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Russia, India, Japan, China, Australia, ASEAN, GCC and South Africa.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Rare Diseases Market Report 2021-2031

As lockdowns were imposed in all the countries, diagnosis rates went down in majority of countries during the year hitting the drug sales for some period. Although lockdown measures have been eased up in most countries by mid-year 2020, this trend is expected to continue beyond 2020, stock up of medicines by patients is likely to propel the drug sales in majority of the developed economies, which account for majority of rare diseases.

02 March 2021

Read

Visiongain Publishes Respiratory Inhalers Market Report 2021-2031

Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Jan 2021.

26 February 2021

Read

Visiongain Publishes Bile Duct Cancer Drugs Market Report to 2031

The global bile duct cancer drug market has been growing considerably owing to the rising incidence and prevalence rate of bile duct cancer patients worldwide, technological advancement in drug development, and healthcare spending.

22 February 2021

Read

Visiongain Publishes Big Data Analytics in Healthcare Market Report to 2031

The global Big Data Analytics in Healthcare market has been growing considerably owing to the rising technological advancement, growing investment, and cohesive government policies.

22 February 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever